Skip to content

Ultrasound-Guided Serratus Anterior Plane Block for Additional Pain Relief After Lung Surgery

Addition of Ultrasound-Guided Serratus Anterior Plane Block to an Enhanced Recovery Pathway for Thoracoscopic Lung Resection: A Randomized Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04238455
Enrollment
93
Registered
2020-01-23
Start date
2020-01-22
Completion date
2024-11-15
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Surgery

Keywords

Serratus Anterior Plane Block, segmentectomy, lobectomy, 19-470

Brief summary

The purpose of this study is to see if an anesthesia technique called serratus anterior plane block may provide additional pain relief for the chest wall after lung surgery. The study will evaluate the effect the serratus anterior plane block technique has on the need for opioids after surgery,the level of pain during recovery, and other aspects of recovery, like whether the patient has nausea and their ability to breathe deeply. The effects of the serratus anterior plane block will be compared to the effects of an inactive (sham) block.

Interventions

PROCEDURESham serratus anterior plane block

The serratus anterior plane block will be performed by the anesthesiology team just prior to emergence from general anesthesia.

PROCEDURESerratus anterior plane block

The serratus anterior plane block will be performed by the anesthesiology team just prior to emergence from general anesthesia.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

This is a two-arm randomized study of chest wall nerve blocks for postoperative analgesia after elective minimally invasive lung resection. The two study groups are: (1) usual care plus serratus anterior plane block (treatment arm), and (2) usual care plus sham serratus anterior plane block (control arm).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients ≥ 18 years of age who are capable of giving consent. English language proficiency is required. * Undergoing elective minimally invasive (VATS or RATS) anatomic lung resection (segmentectomy or lobectomy) without an epidural.

Exclusion criteria

* Pregnancy (Patients must have a negative pregnancy test within 30 days of the operation) * History of documented anaphylaxis or contraindication to local anesthetics * History of ipsilateral thoracic surgery. Ipsilateral thoracic surgery indicates any previous thoracoscopic or open (i.e. via thoracotomy) pleural biopsy, lung resection, esophageal surgery, chest wall resection, or other thoracic surgery within the chest cavity. This does not include image-guided lung biopsy. Note: Mediport placement and other procedures performed by a surgeon/proceduralist NOT within the chest cavity are not excluded. Likewise, patients with a history of ipsilateral breast surgery are also not excluded. The purpose is to exclude patients who may have had injury to the intercostal nerves from previous surgery or who have surgically altered anatomy of the hemithorax. * Patients undergoing bilateral procedures * Weight \< 50 kg * Chronic sustained-release opioid use for \> 2 weeks duration (in the 30 days prior to surgery) * Significant cognitive impairment or documented psychological impairment * American Society of Anesthesiologists (ASA) physical status \> 3 * Patients may also be excluded from the study if the block is deemed not technically feasible (this may be determined intraoperatively).

Design outcomes

Primary

MeasureTime frameDescription
number of patients requiring opioidswithin 24 hours post-operationAssessment of this outcome will be performed by abstracting total dosage of opioids administered during this time period from the electronic medical record (EMR). Opioid dosages will be converted to intravenous morphine sulfate equivalent.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026